Quantum Capital Management Cut Computer Programs & Sys (CPSI) Position By $2.29 Million; 18 Bullish Analysts Covering Medtronic plc (MDT)

February 20, 2018 - By mmahotstuff

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 79 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, August 22. Stifel Nicolaus maintained the stock with “Hold” rating in Thursday, May 25 report. The firm earned “Buy” rating on Friday, May 26 by Oppenheimer. On Wednesday, June 1 the stock rating was downgraded by BTIG Research to “Neutral”. The firm earned “Hold” rating on Wednesday, November 22 by Stifel Nicolaus. The company was maintained on Wednesday, April 19 by RBC Capital Markets. The firm has “Equal-Weight” rating given on Monday, February 5 by Morgan Stanley. Needham maintained Medtronic plc (NYSE:MDT) on Friday, August 26 with “Buy” rating. The stock of Medtronic plc (NYSE:MDT) earned “Overweight” rating by Barclays Capital on Wednesday, August 23. The firm has “Hold” rating given on Tuesday, August 22 by BTIG Research. See Medtronic plc (NYSE:MDT) latest ratings:

05/02/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $91 New Target: $95 Maintain
03/01/2018 Broker: Evercore Rating: Outperform New Target: $92.5 Initiates Coverage On
02/01/2018 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade
12/12/2017 Broker: Argus Research Rating: Buy New Target: $95.0 Upgrade
12/12/2017 Broker: BMO Capital Markets Rating: Buy New Target: $94.0 Maintain
21/11/2017 Broker: Jefferies Rating: Buy New Target: $99.0 Maintain
22/11/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $85.0 Maintain
21/11/2017 Broker: Needham Rating: Buy New Target: $95.0 Maintain
17/11/2017 Broker: SunTrust Rating: Buy New Target: $92.0 Maintain
10/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $89.0 Maintain

Quantum Capital Management Llc decreased Computer Programs & Sys Inc (CPSI) stake by 8.55% reported in 2017Q3 SEC filing. Quantum Capital Management Llc sold 79,010 shares as Computer Programs & Sys Inc (CPSI)’s stock rose 26.52%. The Quantum Capital Management Llc holds 844,992 shares with $24.97 million value, down from 924,002 last quarter. Computer Programs & Sys Inc now has $421.26M valuation. The stock increased 0.08% or $0.025 during the last trading session, reaching $31.325. About 28,217 shares traded. Computer Programs and Systems, Inc. (NASDAQ:CPSI) has declined 20.44% since February 20, 2017 and is downtrending. It has underperformed by 37.14% the S&P500.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.50, from 1.46 in 2017Q2. It dropped, as 19 investors sold CPSI shares while 34 reduced holdings. 14 funds opened positions while 37 raised stakes. 12.15 million shares or 11.10% less from 13.67 million shares in 2017Q2 were reported. Brown Brothers Harriman And reported 0.19% of its portfolio in Computer Programs and Systems, Inc. (NASDAQ:CPSI). Zurcher Kantonalbank (Zurich Cantonalbank) owns 854 shares. Ameritas Prtnrs stated it has 0% in Computer Programs and Systems, Inc. (NASDAQ:CPSI). 48,338 were reported by Wells Fargo & Company Mn. River Road Asset Mgmt Lc holds 0.45% in Computer Programs and Systems, Inc. (NASDAQ:CPSI) or 774,755 shares. Vanguard Inc has invested 0% in Computer Programs and Systems, Inc. (NASDAQ:CPSI). Goldman Sachs Gp Inc stated it has 42,836 shares. Prudential Fin Inc invested in 18,684 shares. Credit Suisse Ag has invested 0% in Computer Programs and Systems, Inc. (NASDAQ:CPSI). Aperio Gp holds 0% or 16,864 shares in its portfolio. Axa invested in 39,500 shares or 0.01% of the stock. Savings Bank Of Mellon Corporation invested 0% in Computer Programs and Systems, Inc. (NASDAQ:CPSI). Blackrock owns 0% invested in Computer Programs and Systems, Inc. (NASDAQ:CPSI) for 1.45 million shares. Francisco Management Lp stated it has 19.04% in Computer Programs and Systems, Inc. (NASDAQ:CPSI). Invesco Limited reported 0% of its portfolio in Computer Programs and Systems, Inc. (NASDAQ:CPSI).

Since August 25, 2017, it had 0 insider purchases, and 2 selling transactions for $177,120 activity. $87,030 worth of Computer Programs and Systems, Inc. (NASDAQ:CPSI) shares were sold by DYE DAVID A.

Among 14 analysts covering Computer Progams & Systems (NASDAQ:CPSI), 3 have Buy rating, 2 Sell and 9 Hold. Therefore 21% are positive. Computer Progams & Systems had 38 analyst reports since July 31, 2015 according to SRatingsIntel. RBC Capital Markets maintained Computer Programs and Systems, Inc. (NASDAQ:CPSI) rating on Monday, November 2. RBC Capital Markets has “Sector Perform” rating and $43 target. As per Friday, February 9, the company rating was maintained by Piper Jaffray. The stock of Computer Programs and Systems, Inc. (NASDAQ:CPSI) has “Sector Perform” rating given on Monday, November 30 by RBC Capital Markets. As per Friday, July 31, the company rating was downgraded by Topeka Capital Markets. The stock has “Hold” rating by Deutsche Bank on Tuesday, December 1. The stock has “Buy” rating by Topeka Capital Markets on Friday, January 29. Robert W. Baird maintained the shares of CPSI in report on Monday, October 2 with “Hold” rating. The stock of Computer Programs and Systems, Inc. (NASDAQ:CPSI) has “Hold” rating given on Friday, October 30 by Topeka Capital Markets. Robert W. Baird upgraded the stock to “Outperform” rating in Wednesday, November 25 report. The stock of Computer Programs and Systems, Inc. (NASDAQ:CPSI) earned “Buy” rating by Suntrust Robinson on Monday, December 14.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $110.77 billion. The companyÂ’s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 22.51 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

The stock decreased 1.76% or $1.47 during the last trading session, reaching $81.84. About 2.44M shares traded. Medtronic plc (NYSE:MDT) has risen 4.04% since February 20, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Investors sentiment increased to 1.12 in Q3 2017. Its up 0.22, from 0.9 in 2017Q2. It increased, as 73 investors sold Medtronic plc shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. Montag A Assocs stated it has 0.06% of its portfolio in Medtronic plc (NYSE:MDT). Augustine Asset holds 2.22% of its portfolio in Medtronic plc (NYSE:MDT) for 44,686 shares. Tekla Cap Limited owns 580,326 shares or 1.61% of their US portfolio. Riverpoint Cap Mgmt Limited Liability Com stated it has 59,233 shares or 0.3% of all its holdings. Farr Miller & Washington Ltd Liability Corporation Dc, a -based fund reported 298,264 shares. Orleans Capital Management La owns 1.8% invested in Medtronic plc (NYSE:MDT) for 30,963 shares. First Fincl In owns 0.05% invested in Medtronic plc (NYSE:MDT) for 1,046 shares. Rench Wealth Incorporated holds 30,125 shares or 1.61% of its portfolio. Klingenstein Fields Limited Liability Corporation stated it has 356,122 shares. Cardinal Capital Mgmt accumulated 54,083 shares. Assets Investment Management Lc reported 80,902 shares. Amp Cap Invsts Ltd reported 694,405 shares. 1,396 were accumulated by Acropolis Invest Mngmt Ltd Liability Company. Dowling And Yahnke Lc has 0.21% invested in Medtronic plc (NYSE:MDT) for 26,316 shares. Moreno Evelyn V invested 1.89% of its portfolio in Medtronic plc (NYSE:MDT).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>